AGP

Artia Global Partners Portfolio holdings

AUM $389M
1-Year Est. Return 34.68%
This Quarter Est. Return
1 Year Est. Return
+34.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$341M
AUM Growth
+$93M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$78.4M
2
+$18M
3
+$13.1M
4
INSM icon
Insmed
INSM
+$11.5M
5
DGX icon
Quest Diagnostics
DGX
+$9.6M

Top Sells

1
+$17.2M
2
+$13.3M
3
+$8.04M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.51M
5
RVMD icon
Revolution Medicines
RVMD
+$6.36M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$725B
$78.4M 19.84%
+94,887
SLNO icon
2
Soleno Therapeutics
SLNO
$3.48B
$35.6M 9.01%
498,473
+4,049
VRNA
3
DELISTED
Verona Pharma
VRNA
$34.2M 8.65%
538,488
+283,170
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$29M 7.34%
219,719
INSM icon
5
Insmed
INSM
$35.5B
$24.3M 6.15%
318,239
+150,300
MRUS icon
6
Merus
MRUS
$7.16B
$17.9M 4.52%
424,640
-39,200
PTGX icon
7
Protagonist Therapeutics
PTGX
$4.77B
$16.1M 4.09%
333,851
+40,000
ACLX icon
8
Arcellx
ACLX
$4.81B
$15M 3.8%
229,085
-700
AZN icon
9
AstraZeneca
AZN
$258B
$14M 3.55%
190,752
BSX icon
10
Boston Scientific
BSX
$148B
$13.1M 3.31%
+129,700
DGX icon
11
Quest Diagnostics
DGX
$21.3B
$9.6M 2.43%
+56,717
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$62.1B
$7.72M 1.95%
28,600
-27,800
ARGX icon
13
argenx
ARGX
$52.3B
$6.69M 1.69%
11,311
NUVL icon
14
Nuvalent
NUVL
$7.01B
$6.44M 1.63%
90,745
-113,300
SRRK icon
15
Scholar Rock
SRRK
$2.71B
$5.54M 1.4%
+172,185
RVMD icon
16
Revolution Medicines
RVMD
$10.1B
$3.68M 0.93%
104,190
-180,000
RYTM icon
17
Rhythm Pharmaceuticals
RYTM
$7.46B
$2.65M 0.67%
50,000
SWTX
18
DELISTED
SpringWorks Therapeutics
SWTX
$2.38M 0.6%
53,930
VKTX icon
19
Viking Therapeutics
VKTX
$3.71B
$2.18M 0.55%
90,279
VRDN icon
20
Viridian Therapeutics
VRDN
$1.96B
$2.16M 0.55%
160,000
+60,000
TGTX icon
21
TG Therapeutics
TGTX
$5.57B
$2.15M 0.54%
54,515
ISRG icon
22
Intuitive Surgical
ISRG
$166B
$1.73M 0.44%
+3,500
EYPT icon
23
EyePoint Pharmaceuticals
EYPT
$954M
$1.72M 0.43%
316,700
+100,000
NBIX icon
24
Neurocrine Biosciences
NBIX
$14B
$1.63M 0.41%
14,700
-30,300
UTHR icon
25
United Therapeutics
UTHR
$19.6B
$1.54M 0.39%
+5,000
1
2